A multicenter, prospective, randomized, controlled trial evaluating the safety and efficacy of intracoronary cell infusion mobilized with granulocyte colony-stimulating factor and darbepoetin after acute myocardial infarction: study design and rationale of the 'MAGIC cell-5-combination cytokine trial'
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|20 Oct 2010||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|27 Oct 2010||Author responded||Author comments - Hyo-Soo Kim|
|Resubmission - Version 3|
|27 Oct 2010||Submitted||Manuscript version 3|
|3 Dec 2010||Reviewed||Reviewer Report - Lawrence Friedman|
|8 Dec 2010||Author responded||Author comments - Hyo-Soo Kim|
|Resubmission - Version 4|
|8 Dec 2010||Submitted||Manuscript version 4|
|16 Dec 2010||Reviewed||Reviewer Report - Lawrence Friedman|
|26 Jan 2011||Author responded||Author comments - Hyo-Soo Kim|
|Resubmission - Version 5|
|26 Jan 2011||Submitted||Manuscript version 5|
|7 Feb 2011||Editorially accepted|
|7 Feb 2011||Article published||10.1186/1745-6215-12-33|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.